Back to top
more

Novavax (NVAX)

(Delayed Data from NSDQ)

$9.35 USD

9.35
4,422,333

-0.26 (-2.71%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $9.42 +0.07 (0.75%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (89 out of 250)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know

Novavax (NVAX) closed the most recent trading day at $140.69, moving +1.78% from the previous trading session.

3 Small Biotechs in Focus on Promising Coronavirus Vaccine Data

Pfizer (PFE) and AstraZeneca (AZN) announce promising data from early-stage coronavirus vaccine studies. Here we discuss three leading biotechs with potential to recshare price gains.

Vaxart's Soars YTD on Robust Coronavirus Vaccine Progress

Vaxart's (VXRT) oral coronavirus vaccine candidate is chosen by Operation Warp Speed for a vaccine study. Last month, the company picked its lead COVID-19 vaccine candidate.

Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know

Novavax (NVAX) closed the most recent trading day at $111.15, moving +1.07% from the previous trading session.

The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Moderna, Novavax and Johnson & Johnson

The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Moderna, Novavax and Johnson & Johnson

The Zacks Analyst Blog Highlights: Etsy, TMobile US, Anthem, Novavax and Southwest Gas

The Zacks Analyst Blog Highlights: Etsy, TMobile US, Anthem, Novavax and Southwest Gas

Tirthankar Chakraborty headshot

Race to Coronavirus Vaccine Heats Up: 5 Stocks in Spotlight

Two experimental coronavirus vaccines, manufactured jointly by Pfizer and BioNTech, have received fast track status from the FDA.

Do Options Traders Know Something About Novavax (NVAX) Stock We Don't?

Investors need to pay close attention to Novavax (NVAX) stock based on the movements in the options market lately.

Has Novavax (NVAX) Outpaced Other Medical Stocks This Year?

Is (NVAX) Outperforming Other Medical Stocks This Year?

Novavax, Inc. (NVAX) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Novavax, Inc. (NVAX).

Tirthankar Chakraborty headshot

Coronavirus to Cast a Pall Over Q2 Earnings: 5 Stocks to Stand Out

It will be prudent to invest in companies from the tech, healthcare and utility sectors, which are expected to have suffered less compared to others in Q2.

Emergent (EBS) Stock Up Year to Date on Coronavirus Vaccine Deals

Emergent (EBS) inks deals with multiple companies to provide manufacturing services for helping them develop COVID-19 vaccine.

Biotech Stock Roundup: REGN Initiates Coronavirus Study, NVAX Surges & More

The biotech sector remains in focus with updates on coronavirus treatments and other pipeline updates.

Company News for Jul 8, 2020

Companies In The News Are: WMT, NVAX, DOCU, REGN.

Novovax Up on $1.6B Federal Funding for Coronavirus Program

Novovax (NVAX) is evaluating a coronavirus vaccine candidate, NVX-CoV2373, in a phase I/II study. A pivotal study is due to start in the fourth quarter.

Emergent's (EBS) 5-Year Deal to Back J&J's Coronavirus Vaccine

Emergent BioSolutions (EBS) extends a five-year deal with J&J to provide its CDMO services to produce the drug substance of the latter's COVID-19 vaccine candidate. Shares rise.

Kinjel Shah headshot

FDA Issues Guidance for Coronavirus Vaccine Developers

Around a dozen companies are developing a vaccine for the deadly coronavirus disease.

Sanghamitra Saha headshot

Top Leveraged ETFs of Last Week

Leveraged gold miners and treasury ETFs gained last week despite a market crash.

The Zacks Analyst Blog Highlights: Microvision, Veritone, Remark, Novavax and DCP

The Zacks Analyst Blog Highlights: Microvision, Veritone, Remark, Novavax and DCP

Sweta Killa headshot

Growth Investing Leads in 1H: 5 Top ETFs & Stocks

Growth investing took a lead so far this year courtesy of massive money flowing into the economy.

The Zacks Analyst Blog Highlights: Zoom Video, Quidel, Zscaler, Datadog and Novavax

The Zacks Analyst Blog Highlights: Zoom Video, Quidel, Zscaler, Datadog and Novavax

Anirudha Bhagat headshot

Fears of a Second Wave of Coronavirus are Aiding These 5 Stocks

Here we pick five stocks which have potentials to gain in situations if the stock market is hit by the second wave of the coronavirus pandemic.

Tirthankar Chakraborty headshot

Wall Street Readies for Best Quarter Ever: 5 Picks

The S&P 500 is up 21.2% so far in Q2 and is on pace for its biggest quarterly gain since Q1 of 1975. Similarly, the Nasdaq is up 31.6% since the end of Q1, putting it on pace for its second-best quarter ever.

Sweta Killa headshot

5 Top-Ranked Stocks That Made Nasdaq Outperform in 1H

The tech-heavy Nasdaq Composite Index has outperformed so far this year, having gained 12% in comparison to losses of 3.5%for the S&P 500 and 8.8% for Dow Jones.

Aniruddha Ganguly headshot

5 Nasdaq Stocks That Have Returned More Than 100% YTD

Here we discuss five Nasdaq-listed stocks that have gained more than 100% year to date and are well-poised to grow further on solid prospects.